SCHEMBL3772073

SCHEMBL3772073

ClC(I)C1CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL965871 0.72
SCHEMBL6007125 0.72
SCHEMBL10897924 0.67
SCHEMBL126821 0.67
SCHEMBL7742422 0.67
SCHEMBL9065462 0.67
SCHEMBL2550428 0.67
Water SCHEMBL9180807 0.65
SCHEMBL153229 0.65
SCHEMBL12336470 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7850790-B2 Reactive gases with concentrations of increased stability and processes for manufacturing same AMERICAN AIR LIQUIDE, INC. (US) 2010-12-14 US disclosed
US-20090223594-A1 Reactive Gases With Concentrations Of Increased Stability And Processes For Manufacturing Same AMERICAN AIR LIQUIDE INC. (US) 2009-09-10 US disclosed
EP-2066668-A1 SPIROCYCLIC AZETIDINONE DERIVATIVES FOR THE TREATMENT OF DISORDERS OF LIPID METABOLISM, PAIN, DIABETES AND OTHER DISORDERS SCHERING CORPORATION (US) 2009-06-10 EP disclosed
WO-2008033431-A1 SPIROCYCLIC AZETIDINONE DERIVATIVES FOR THE TREATMENT OF DISORDERS OF LIPID METABOLISM, PAIN, DIABETES AND OTHER DISORDERS SCHERING CORPORATION (US) 2008-03-20 WO disclosed
EP-0198949-A1 A proces and installation for destroying hazardous wastes Shultz, Clifford G. (US) 1986-10-29 EP disclosed